CD10 y mesotelioma maligno. A propósito de un caso

Alameda Quitllet, Francesc; Moysset Agustí, Irene; Lloreta Trull, Josep; Baró Tomás, Teresa; Magán Perea, Luis; Badal Alter, Josep; Serrano Figueras, Sergi.
Rev. esp. patol ; 39(1): 54-58, abr. 2006. ilus, tab
Artículo en Es | IBECS (España) | ID: ibc-049666

Documentos relacionados

  1. Review of the impact of the International System for Serous Fluid Cytopathology.
  2. [Well-differentiated papillary mesothelial tumor of the peritoneum: report of a case].
  3. Cytological features in ascitic fluid of well-differentiated papillary mesothelial tumour.
  4. Endobronchial ultrasound guided transbronchial needle aspirate from subcarinal lymph node: Mesothelial lesion, a diagnostic dilemma.
  5. L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well-differentiated papillary mesothelial tumours and malignant mesotheliomas.
  6. Benign mesothelial mesenteric cyst: case report and literature review.
  7. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
  8. Solid papillary mesothelial tumor.
  9. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
  10. CD10<sup>+</sup>GPR77<sup>+</sup> Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.